Kaneko Y, Hatano R, Hirota N, Isambert N, Trillet-Lenoir V, You B, Alexandre J, Zalcman G, Valleix F, Podoll T, Umezawa Y, Takao S, Iwata S, Hosono O, Taguchi T, Yamada T, Dang NH, Ohnuma K, Angevin E, Morimoto C (2021)
Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody
Biomark Res 9: 21

Pan K, Ohnuma K, Morimoto C, Dang NH (2021)
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions
Cureus 13: e13495

Sato T, Tatekoshi A, Takada K, Iyama S, Kamihara Y, Jawaid P, Rehman MU, Noguchi K, Kondo T, Kajikawa S, Arita K, Wada A, Murakami J, Arai M, Yasuda I, Dang NH, Hatano R, Iwao N, Ohnuma K, Morimoto C (2019)
DPP8 is a novel therapeutic target for multiple myeloma
Sci Rep 9: 18094

Ohnuma K, Hatano R, Komiya E, Otsuka H, Itoh T, Iwao N, Kaneko Y, Yamada T, Dang NH, Morimoto C (2018)
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target
Front Biosci (Landmark Ed) 23: 1754

Ohnuma K, Haagmans BL, Hatano R, Raj VS, Mou H, Iwata S, Dang NH, Bosch BJ, Morimoto C (2013)
Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody
J Virol 87: 13892

Shirakawa J, Fujii H, Ohnuma K, Sato K, Ito Y, Kaji M, Sakamoto E, Koganei M, Sasaki H, Nagashima Y, Amo K, Aoki K, Morimoto C, Takeda E, Terauchi Y (2011)
Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice
Diabetes 60: 1246

Takasawa W, Ohnuma K, Hatano R, Endo Y, Dang NH, Morimoto C (2010)
Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines
Biochemical & Biophysical Research Communications 401: 7

Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C, Dang NH (2008)
The role of CD26/dipeptidyl peptidase IV in cancer
Front Biosci 13: 1634

Ohnuma K, Takahashi N, Yamochi T, Hosono O, Dang NH, Morimoto C (2008)
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
Front Biosci 13: 2299

Thompson MA, Ohnuma K, Abe M, Morimoto C, Dang NH (2007)
CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders
Mini Rev Med Chem 7: 253

Ohnuma K, Inoue H, Uchiyama M, Yamochi T, Hosono O, Dang NH, Morimoto C (2006)
T-cell activation via CD26 and caveolin-1 in rheumatoid synovium
Mod Rheumatol 16: 3

Ohnuma K, Yamochi T, Uchiyama M, Nishibashi K, Iwata S, Hosono O, Kawasaki H, Tanaka H, Dang NH, Morimoto C (2005)
CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells
Molecular & Cellular Biology 25: 7743

Yamochi T, Aytac U, Sato T, Sato K, Ohnuma K, McKee KS, Morimoto C, Dang NH (2005)
Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin
Cancer Research 65: 1973

Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C (1993)
Direct association of adenosine deaminase with a T cell activation antigen, CD26
Science 261: 466

Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C (1992)
Cloning and functional expression of the T cell activation antigen CD26
J Immunol 149: 481